Illustrating the circuits of sexual desire

Journal of Clinical Psychiatry

Volumn 71, Issue 9, 2010, Pages 1113-1114

  Stahl, Stephen M ^a,b,c  

^a NEUROSCIENCE EDUCATION INSTITUTE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; BUSPIRONE; CYPROHEPTADINE; DOPAMINE; ENDOCANNABINOID; FLIBANSERIN; GLUTAMIC ACID; MELANOCORTIN; MIRTAZAPINE; OPIATE; OXYTOCIN; SEROTONIN; TRAZODONE; AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS;

DEPRESSION; DRUG MECHANISM; ENDOCRINE DISEASE; GABAERGIC SYSTEM; HYPOACTIVE SEXUAL DESIRE DISORDER; HYPOTHALAMUS; INTERNEURON; LIBIDO; LIMBIC CORTEX; NUCLEUS ACCUMBENS; PREFRONTAL CORTEX; PRIORITY JOURNAL; SEXUAL BEHAVIOR; SEXUAL DYSFUNCTION; SHORT SURVEY; SIGNAL TRANSDUCTION; VENTRAL TEGMENTUM; EMOTION; HUMAN; LIMBIC SYSTEM; METABOLISM; NERVE CELL NETWORK; PATHOPHYSIOLOGY; PHYSIOLOGY; PSYCHOLOGY; SEXUAL DYSFUNCTIONS, PSYCHOLOGICAL;

EMOTIONS; HUMANS; HYPOTHALAMUS; LIMBIC SYSTEM; NERVE NET; NEUROTRANSMITTER AGENTS; PREFRONTAL CORTEX; SEXUAL DYSFUNCTIONS, PSYCHOLOGICAL;

EID: 77957854432     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.10bs06425whi     Document Type: Short Survey

References (12)

1. Stahl SM. Circuits of sexual desire in hypoactive sexual desire disorder. J Clin Psychiatry. 2010;71(5):518-519. doi:10.408/JCP.10bs0615whi PubMed
2. Pfaus JG. Pathways of sexual desire. J Sex Med. 2009;6(6):1506-1533. doi:10.1/j.1743-6109.209.01309.x PubMed
3. Arnow BA, Millheiser L, Garrett A, et al. Women with hypoactive sexual desire disorder compared to normal females: a functional magnetic resonance imaging study. Neuroscience. 2009;158(2):484-502. doi:10.1016/j.neuroscience. 208.09.04 PubMed
4. Holstege G, Willemsen A, Beers C, et al. Differences in brain activity in premenopausal women with hypoactive sexual desire disorder (HSDD) compared to women without sexual dysfunction. Abstracts of the 12th Congress of the European Society for Sexual Medicine (ESSM), November 15-18, 2009; Lyon, France. PS-02-002.
5. Stahl SM. Targeting circuits of sexual desire as a treatment strategy for HSDD (hypoactive sexual desire disorder). J Clin Psychiatry. 2010;71(7):821-822. doi:10.408/JCP.10bs0617blu
6. Bortolozzi A, Díaz-Mataix L, Scorza MC, et al. The activation of 5-HT receptors in prefrontal cortex enhances dopaminergic activity. J Neurochem. 2005;95(6):1597-1607. doi:10.1/j.1471-4159.205.03485.x PubMed (Pubitemid 41804057)
7. Invernizzi RW, Sacchetti G, Parini S, et al. Flibanserin, a potential antidepressant drug, lowers 5-HT and raises dopamine and noradrenaline in the rat prefrontal cortex dialysate: role of 5-HT(1A) receptors. Br J Pharmacol. 2003;139(7):1281-1288. doi:10.1038/sj.bjp.0705341 PubMed (Pubitemid 37026411)
8. Jolly E, Clayton A, Thorp J, et al. Efficacy of flibanserin 100 mg qhs as a potential treatment for hypoactive sexual desire disorder in premenopausal women. Abstracts of the 12th Congress of the European Society for Sexual Medicine (ESSM). November 15-18, 2009; Lyon, France. PS-02-008.
9. Stahl SM. Stahl's Essential Psychopharmacology. 3rd ed. New York, NY: Cambridge University Press; 2008.
10. Hadley ME. Discovery that a melanocortin regulates sexual functions in male and female humans. Peptides. 2005;26(10):1687-1689. doi:10.1016/j.peptides. 205.01.023 PubMed
11. Diamond LE, Earle DC, Rosen RC, et al. Double-blind, placebo-controlled evaluation of the safety, pharmacokinetic properties and pharmacodynamic effects of intranasal PT-141, a melanocortin receptor agonist, in healthy males and patients with mild-tomoderate erectile dysfunction. Int J Impot Res. 2004;16(1):51-59. doi:10.1038/sj.ijir.390139 PubMed
12. Rosen RC, Diamond LE, Earle DC, et al. Evaluation of the safety, pharmacokinetics and pharmacodynamic effects of subcutaneously administered PT 141, a melanocortin receptor agonist, in healthy male subjects and in patients with an inadequate response to Viagra. Int J Impot Res. 2004;16(2):135-142. doi:10.1038/sj.ijir.390120